Francoise Dantzer
Illkirch-graffenstaden, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
PARP3: a Swiss army knife orchestrating DNA repair, cancer aggressiveness and cell differentiation
Journal: Medecine sciences : M/S
Published: May 29, 2026
Knockout of PARP2 in T cells leads to spontaneous colitis with distinct segmental characteristics in PARP1-deficient mice.
Journal: Frontiers in immunology
Published: November 07, 2025
PARP inhibition modulates mitochondrial morphology and metabolism under hypoxic stress in cancer cells.
Journal: Cell death & disease
Published: August 23, 2025
Antibody-Vincristine Conjugates as Potent Anticancer Therapeutic Agents.
Journal: Journal of medicinal chemistry
Published: December 16, 2024
Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2024
Enhancing cisplatin drug sensitivity through PARP3 inhibition: The influence on PDGF and G-coupled signal pathways in cancer.
Journal: Chemico-biological interactions
Published: February 16, 2024
PARP2 downregulation in T cells ameliorates lipopolysaccharide-induced inflammation of the large intestine.
Journal: Frontiers in immunology
Published: December 31, 2022
Purification of Recombinant Human PARG and Activity Assays.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 14, 2022
Purification of Recombinant Human PARP-3.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 14, 2022
Last Updated: 09/26/2026